Metoprolol Succinate Tablet, Extended Release
Product Images NDC 27808-304

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 27808-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cranbury Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Metoprolol Succinate Extended Release Tablets 1)

Chemical structure of Metoprolol Succinate depicted with detailed molecular groups including hydroxyl (OH), methoxy (OCH3), and a succinate moiety (COOH groups), indicating its extended molecular form.*

FDA Label Image

Figure (Metoprolol Succinate Extended Release Tablets 2)

A forest plot titled 'Results for Subgroups in MERIT-HE' showing relative risk and 95% confidence intervals for different patient subgroups. It compares Metoprolol Succinate Extended-Release Tablets versus placebo across three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, with subgroup distinctions including region, NYHA class, ejection fraction, ischemic etiology, sex, race, prior myocardial infarction, diabetes status, hypertension history, and heart rate.*

FDA Label Image

25mg 100 Tabs (Metoprolol Succinate Extended Release Tablets 3)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 25 mg strength, oral tablet form. The label states packaging of 100 tablets. It includes storage instructions, manufacturer details Visum Pharmaceutical Co., Ltd. and Cranbury Pharmaceuticals, LLC as the labeler. The label also mentions Rx only and displays the Cranbury Pharmaceuticals logo and an NDC barcode.*

FDA Label Image

50mg 100 Tabs (Metoprolol Succinate Extended Release Tablets 4)

Metoprolol Succinate Extended-Release Tablets, USP 50 mg oral tablets carton label. The label indicates 100 tablets per package, Rx only, manufactured by Visum Pharmaceutical Co., Ltd., distributed by Cranbury Pharmaceuticals, LLC. Includes storage and dosage instructions, a barcode, and a NDC number 27808-303-01.*

FDA Label Image

100mg 100 Tabs (Metoprolol Succinate Extended Release Tablets 5)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 100 mg strength, oral tablet form. The label states the product contains 95 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate per tablet and is packaged in a quantity of 100 tablets. Manufactured by Visum Pharmaceutical Co., Ltd. for Cranbury Pharmaceuticals, LLC. Includes storage instructions and a barcode.*

FDA Label Image

200mg 100 Tabs (Metoprolol Succinate Extended Release Tablets 6)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 200 mg strength in oral tablet form. The package contains 100 tablets. The label includes dosage information, storage instructions, and manufacturer details, indicating Cranbury Pharmaceuticals, LLC as the labeler and Visum Pharmaceutical Co., Ltd. as the manufacturer. Barcode and NDC 27808-305-01 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.